Navigation Links
Systems Biology poised to revolutionize the understanding of cell function and disease
Date:9/7/2007

Systems Biology is transforming the way scientists think about biology and disease. This novel approach to research could prompt a shake up in medical science and it might ultimately allow clinicians to predict and treat complex diseases such as diabetes, heart failure, cancer, and metabolic syndrome for which there are currently no cures.

The European Science Foundation (ESF) has published a Forward Look (FL) report System Biology: a grand challenge for Europe; an attempt to identify how research in Systems Biology could be accelerated and developed further in Europe. The report concludes with a set of specific recommendations that aims at consolidating Systems Biology efforts in Europe. The idea of this ESF initiated FL first came to light with a proposal by the Netherlands Organization for Health Research and Development (ZonMw) and the NWO Council for Earth and Life Sciences in the Netherlands. The proposal was later materialised into concrete effort based on extensive discussions during a number of focused workshops and meetings between scientists and policy makers from academia and industry.

The report, which includes 12 essays from the scientific experts in academia and industry, illustrates Europes potential to be at the forefront of pinpointing the system causes of diseases, according to Dr. John Marks, the chief executive of the ESF.

The report tells us it is necessary to develop a well coordinated effort, bringing together the many different research activities in Europe, and complement this with joint development of basic technologies, reference labs and training a new generation of researchers, adds Marks.

Until recently, researchers tended to focus on identifying individual genes and proteins and pinpointing their role in the cell or the human body. But molecules almost never act alone. According to Lilia Alberghina from the University of Milano-Bicocca, Italy: There is a growing awareness in medical science
'/>"/>

Contact: Thomas Lau
tlau@esf.org
33-388-762-158
European Science Foundation
Source:Eurekalert

0

GOOD

Page: 1 2 3 4 5

Related biology news :

1. Open microfluidic and nanofluidic systems
2. Applied Biosystems Introduces Advanced Gene Expression Service Provider Program
3. Institute for Systems Biology Symposium Addresses Need for Better Computational Tools
4. Scientists Propose Sweeping Changes to Naming of Bird Neurosystems to Acknowledge Their True Brainpower
5. Different microarray systems more alike than previously thought
6. Integration of Agilents MS technology, Proteome Systems software to help scientists in proteomics research
7. Changing ecosystems throw scientists mega-challenges
8. Scripps scientists find potential for catastrophic shifts in Pacific ecosystems
9. A new way to share models of biological systems
10. Motor transport in bio-nano systems
11. Invitrogen Launches i-Path -- A Unique Systems Biology Platform at BIO 2005
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2012)... Athens, Ga. The rate at which the rabies ... ecological traits of its hosts, according to researchers at ... Control and Prevention and Katholieke Universiteit Leuven in Belgium. ... PLoS Pathogens , found that the host,s geographical location ... of evolution. Rabies viruses in tropical and sub-tropical bat ...
(Date:5/18/2012)... everyday life, we use gasoline, diesel, plastics, rubbers, ... oil through petrochemical refinery processes. However, this is ... fossil resources. Furthermore, our world is facing problems ... due to the increasing use of fossil resources. ... use of renewable non-food biomass for the production ...
(Date:5/18/2012)... the winners of their 6th Annual Research Awards ... the very best research that has been made ... guests attended the prestigious ceremony including leading researchers, ... world. , The winners were selected by ... journals which published more than 18,000 peer-reviewed open ...
Breaking Biology News(10 mins):Hitting snooze on the molecular clock: Rabies evolves slower in hibernating bats 2Hitting snooze on the molecular clock: Rabies evolves slower in hibernating bats 3Production of chemicals without petroleum 2BioMed Central announces winners of 6th Annual Research Awards 2Pharmacists Offer Guidance on Top Over The Counter Medications 16616 1Pharmacists Offer Guidance on Top Over The Counter Medications 16616 2Pharmacists Offer Guidance on Top Over The Counter Medications 16616 3Researchers report widespread use of medications among pregnant women 81301 1Researchers report widespread use of medications among pregnant women 81301 2Rice born detector finds heaviest antimatter 18956 1Rice born detector finds heaviest antimatter 18956 2Rice born detector finds heaviest antimatter 18956 3
... Metabolic syndrome, a collection of related abnormalities like ... a major risk for developing heart disease and ... cholesterol (familial hyperlipidemia or FH) can be especially ... found that blocking the enzyme stearoyl-CoA desaturase-1 (SCD1), ...
... bioengineer Jennifer West is being recognized today with one ... O,Donnell Award from The Academy of Medicine, Engineering and ... for excellence in medical, scientific and engineering research, include ... West, a pioneer in the field of biomaterials engineering, ...
... the Stanford University Program in Biodesign have released ... requirements of medical device regulation in the United ... 2007 issue of the Journal of Medical Devices, ... versus pharmaceuticals and underscores the complexity of the ...
Other Biology News:Rice's West honored as one of Texas' best researchers 2Rice's West honored as one of Texas' best researchers 3Stanford researchers publish review of US medical device regulation 2Stanford researchers publish review of US medical device regulation 3
(Date:5/16/2012)... Calif., May 16, 2012  Questcor Pharmaceuticals, Inc. ... its Board of Directors has increased the Company,s ... 5 million shares. Since the beginning ... to shareholders through the repurchase of approximately 19.2 ... of its shares as of the commencement of ...
(Date:5/15/2012)... Journal of Visualized Experiments ) will publish two articles ... Reduction Agency (DTRA). JoVE is proud ... Schafmeister and State University of New York Buffalo,s Dr. ... support of scientists conducting research for DTRA has significant ... defense threats. DTRA exists to safeguard America and its ...
(Date:5/15/2012)... May 15, 2012  OrbusNeich today announced that 12-month ... and safety outcomes involving the use of the company,s ... ® Liberte ® paclitaxel-eluting stent. The data ... I at the Lukaskrankenhaus in Neuss, Germany, at EuroPCR ... set, the clinically driven target lesion failure (TLF) rate ...
(Date:5/15/2012)... Generex Biotechnology Corporation (OTCBB: GNBT), in anticipation ... trials, is pleased to announce today that the expertise ... subsidiary, Antigen Express, Inc., has been expanded by the ... research and immuno-therapeutic treatments of breast cancer: ... University School of Medicine Melvin and Bren ...
Breaking Biology Technology:Questcor Pharmaceuticals Expands Repurchase Program 2Questcor Pharmaceuticals Expands Repurchase Program 3Questcor Pharmaceuticals Expands Repurchase Program 4Questcor Pharmaceuticals Expands Repurchase Program 5JoVE partners with US government to publish cutting-edge defense research 2OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 2OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 3OrbusNeich's Combo Dual Therapy Stent™ Demonstrates Favorable Clinical and Safety Outcomes at 12-Month Follow-Up 4Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers 2Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers 3Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers 4
... 8 /Xinhua-PRNewswire-FirstCall/ --,China Biologic Products, Inc. (OTC Bulletin ... the leading plasma-based pharmaceutical companies,in the People,s Republic ... present at the upcoming SIG Second Annual Beijing ... the Grand Hyatt Beijing Hotel in Beijing., ...
... 4 weeks of treatment with R7128 1500mg BID with Pegasys(R) plus ... Copegus(R) -, - Safety and ... ... Inc.,(Nasdaq: VRUS ) announces the preliminary results of the fourth cohort of a,4-week Phase ...
... and DUBLIN, Ireland, Sept. 8 /PRNewswire-FirstCall/,-- Concuity, ... TTPA ) and a leading,provider of contract ... HFMA") and services, today announced that Valley ... Compliance suite to more,accurately calculate payments from ...
Other Biology Technology:China Biologic Products to Present at the SIG Beijing Management Summit 2China Biologic Products to Present at the SIG Beijing Management Summit 3Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 2Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 3Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 4Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 5Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 6Valley Baptist Health System Selects Concuity's ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 2Valley Baptist Health System Selects Concuity's ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 3Valley Baptist Health System Selects Concuity's ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers 4